Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
SPEM Dysfunction and General Schizotypy as Measured by the SSQ: A Controlled Study
BMC Neurology, 06/30/09
Kampen DV et al. - The present study provides additional evidence that SPEM dysfunction is associated with schizotypic features that precede the onset of schizophrenia and is already observable in general population subjects that show these features.
Related Articles
Impact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis
European Journal of Echocardiography, 10/19/09
Relevance Score: 46%
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 45%
Neurological Manifestations in Chagas Disease without Cardiac Dysfunction: Correlation between Dysfunction of the Parasympathetic Nervous System and White Matter Lesions in the Brain
Journal of Neuroimaging, 10/13/09
Relevance Score: 45%
Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension
Liver International, 10/08/09
Relevance Score: 45%
Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 45%
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms
Journal of General Internal Medicine, 12/07/09
Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients
Journal of General Internal Medicine, 12/07/09
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


